ACHP Statement on Dr. Oz’s Confirmation as CMS Administrator
ACHP is grateful for its longstanding partnership with CMS and congratulates Dr. Mehmet Oz on his confirmation as CMS Administrator.
Tag: prescription drugs / drug prices
ACHP Letter to FDA Commissioner Dr. Makary
ACHP sent a letter to FDA Commissioner, Dr. Marty Makary, with comments on addressing high prescription drug costs & fostering a more competitive market.
ACHP Statement on Dr. Makary’s Confirmation as FDA Commissioner
ACHP released a statement regarding the confirmation of Dr. Marty Makary as Commissioner of the U.S. Food and Drug Administration.
A Lifeline for Rare Diseases
ACHP calls on Congress to create a national risk pool for cutting-edge cell and gene therapies to mitigate high costs and ensure the right patients have access at a manageable cost.
PBMs are Clear as Mud: The Value of a Fee-Based, Transparent Model
Transparency in the drug supply chain is desperately needed to deliver consumers the lowest cost and highest value prescription drugs.
